Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Severe Combined Immunodeficiency 1Neuroblastoma 1Neoplasms 1Mucopolysaccharidosis I 1Hematologic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1Anus Neoplasms 1

Interventions

Surveys and Questionnaires 5Magnetic Resonance Spectroscopy 3Quality of Life 2Drug Therapy 2Biopsy 2trastuzumab deruxtecan 1Tomography, X-Ray Computed 1Sentinel Lymph Node Biopsy 1Restraint, Physical 1Radiotherapy 1Radionuclide Imaging 1Psychiatric Rehabilitation 1Positron-Emission Tomography 1Patient Reported Outcome Measures 1Observation 1Molecular Diagnostic Techniques 1Mass Screening 1Interviews as Topic 1Immunotherapy 1Immunohistochemistry 1Human Papillomavirus DNA Tests 1Genetic Testing 1Follow-Up Studies 1Chromatin Immunoprecipitation Sequencing 1Blood Specimen Collection 1Biological Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Anus Neoplasms × Follow-Up Studies × Clear all
NCT05130073 2024-02-20

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

M.D. Anderson Cancer Center

Completed
41 enrolled
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡